Nusinersen: the antisense oligonucleotide at the forefront of spinal muscular atrophy treatment

Natalia N. Singh, Eric W. Ottesen, Ravindra N. Singh

Open source

DOI
10.1080/15476286.2026.2675858
Published
2026-05-25
Container
RNA Biology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/15476286.2026.2675858,
  title = {Nusinersen: the antisense oligonucleotide at the forefront of spinal muscular atrophy treatment},
  author = {Natalia N. Singh and Eric W. Ottesen and Ravindra N. Singh},
  year = {2026},
  journal = {RNA Biology},
  doi = {10.1080/15476286.2026.2675858},
  url = {https://doi.org/10.1080/15476286.2026.2675858}
}

RIS

TY  - JOUR
TI  - Nusinersen: the antisense oligonucleotide at the forefront of spinal muscular atrophy treatment
AU  - Natalia N. Singh
AU  - Eric W. Ottesen
AU  - Ravindra N. Singh
PY  - 2026
JO  - RNA Biology
DO  - 10.1080/15476286.2026.2675858
UR  - https://doi.org/10.1080/15476286.2026.2675858
ER  - 

APA

Singh, N. N., Ottesen, E. W., & Singh, R. N. (2026). Nusinersen: the antisense oligonucleotide at the forefront of spinal muscular atrophy treatment. RNA Biology. https://doi.org/10.1080/15476286.2026.2675858

Source records